mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |